Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Neurol Clin. 2012 Nov;30(4):1167–1191. doi: 10.1016/j.ncl.2012.08.011

Table 1. Overview of clinical features and treatment of circadian rhythm sleep disorders (CRSD) *.

Disorder Clinical Features Treatment
Delayed leep phase disorder (DSPD) Stable delay of the major sleep period, resulting in difficulty falling asleep at night and difficulty waking up in the monring Bright ight therapy 2,000-2:500 lux for 2 hours at or 2-3hours prior to habitual rise time
0.5 mg-3mg melatonin 5-7h prior to steep time
Advanced sleep phase disorder (ASPD) Stable advance of the major sleep period, resulting in difficulty staying awake in the evening and difficulty maintaining asleep in the morning Bright light therapy 2,000-2,500 iux for 2h in evening (around 7-9pm)
Non-24 Hour Sleep Wake Disorder (N24HSWD) Chronic and steady 1 to 2 hours daily delay of sleep and wake schedule resutting in insomnia, difficulty waking up in the morning and excessive daytime sleepiness Blind - 0 5mg melatonin 1h before preferred bedtime. Sighted - morning bright light therapy at rise time and/or night melatonin administration
Irregular Sleep-Wake Rhythm (ISWR) Absence of a clearly discernable sleep-wake circadian rhythm resulting in insomnia and/or excessive daytime sleepiness Increase daytime light exposure and social activity
Minimize nighttime light and noise exposure
Evening melatonin administration combined with daytime light exposure
*

Sleep hygiene is an important component to treat CRSD.